| Juleyka Angelis Andino Rivera, ATC | |
|
3303 S Archibald Ave # 1-242, Ontario, CA 91761-7900 | |
| (619) 890-4248 | |
| Not Available |
| Full Name | Juleyka Angelis Andino Rivera |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine - Sports Medicine |
| Location | 3303 S Archibald Ave # 1-242, Ontario, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548887441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PS0010X | Emergency Medicine - Sports Medicine | 2000034110 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Juleyka Angelis Andino Rivera, ATC 3303 S Archibald Ave # 1-242, Ontario, CA 91761-7900 Ph: (619) 890-4248 | Juleyka Angelis Andino Rivera, ATC 3303 S Archibald Ave # 1-242, Ontario, CA 91761-7900 Ph: (619) 890-4248 |
News Archive
While early antibiotic use has been associated with a number of rare long-term health consequences, new research links antibiotics to one of the most important and growing public health problems worldwide - obesity.
Researchers with The Ohio State University College of Medicine, The Ohio State University Wexner Medical Center and Nationwide Children's Hospital have found that a simple urine test can rapidly detect one of the world's deadliest pregnancy-related conditions, which could have a major impact on global health.
In a study that points to a new strategy for preventing or possibly reversing fibrosis - the scarring that can lead to organ and tissue damage - researchers at the University of California, San Diego School of Medicine have determined that a molecule called Epac (Exchange protein activated by cAMP1), plays a key role in integrating the body's pro- and anti-fibrotic response.
Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).
› Verified 4 days ago
Cody Munday, ATC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 W Francis St., Ontario, CA 91762 Phone: 909-988-7411 | |
Sharon Naomi Dabby, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3045 S Archibald Ave, H109, Ontario, CA 91761 Phone: 424-354-4991 |